1. Home
  2. OVBC vs SLGL Comparison

OVBC vs SLGL Comparison

Compare OVBC & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

HOLD

Current Price

$46.65

Market Cap

220.0M

Sector

Finance

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$67.39

Market Cap

218.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVBC
SLGL
Founded
1872
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.0M
218.9M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
OVBC
SLGL
Price
$46.65
$67.39
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $152.50
AVG Volume (30 Days)
13.8K
★ 32.0K
Earning Date
11-03-2026
11-19-2026
Dividend Yield
★ 2.17%
N/A
EPS Growth
★ 42.67
N/A
EPS
★ 1.53
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.81
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.18
$28.81
52 Week High
$51.25
$97.97

Technical Indicators

Market Signals
Indicator
OVBC
SLGL
Relative Strength Index (RSI) 64.20 44.09
Support Level $46.54 $60.91
Resistance Level $47.59 $80.53
Average True Range (ATR) 0.96 4.34
MACD 0.13 -0.53
Stochastic Oscillator 86.34 19.57

Price Performance

Historical Comparison
OVBC
SLGL

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: